MACROPHAGE FATTY ACID METABOLISM IN IMMUNITY TO HELMINTHS
蠕虫免疫中的巨噬细胞脂肪酸代谢
基本信息
- 批准号:9187865
- 负责人:
- 金额:$ 27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-01-13 至 2019-12-31
- 项目状态:已结题
- 来源:
- 关键词:AcetatesAcid LipaseAddressAdipose tissueAdoptedAgonistAttentionCD36 geneCell RespirationCellsChemicalsChronicCitratesCitric Acid CycleCytosolDeveloping CountriesDietDiseaseDistalEnzymesExhibitsFaceFatty AcidsGene ExpressionGenesGeneticGenetic TranscriptionGlucoseGlutamineGrantHelminthsHepatocyteHigh Fat DietHistone AcetylationHomeostasisHost DefenseImmune responseImmunityInfectionInflammationInflammatoryInjection of therapeutic agentInterferon Type IIInterferonsInterleukin-13Interleukin-4LigandsLipolysisLiverMacrophage ActivationMediatingMediator of activation proteinMetabolicMetabolic ControlMetabolic DiseasesMetabolismMitochondriaMorbidity - disease rateNematodaNematospiroides dubiusNutrientObesityOrganOrganismOutcomeOxidative PhosphorylationOxygen ConsumptionParasitesPlatyhelminthsPlayProcessProductionPublicationsReportingResearchResistance to infectionRestRoleSTAT4 proteinSchistosoma mansoniSiteSocietiesSourceSystemT-Cell ProliferationTimeTissuesTriglyceridesWound Healingadaptive immunityaerobic glycolysisburden of illnesscell typecytokinefatty acid metabolismfatty acid oxidationinhibitor/antagonistlipid metabolismloss of functionmacrophagemicrobialneglected tropical diseasesoxidationpathogenpreferenceprogramspublic health relevancereceptorrespiratoryresponsetissue repairtranscription factoruptake
项目摘要
DESCRIPTION (provided by applicant): Helminth parasites are endemic in many developing countries. The overall burden of disease due to these pathogens is high, with approximately 300 million infected people suffering from severe morbidity. Here we will focus on M2 macrophages, which play crucial host protective roles in helminth infections. Macrophages can adopt different activation states depending on context. Interferon-¿ in combination with TLR agonists promotes M1 (or classical) activation, whereas the cytokines IL-4 and IL-13 promote M2 (or alternative) activation. Differential functions in M1 and M2 macrophages are supported by distinct core metabolisms, with M1 cells committing to aerobic glycolysis, and M2 macrophages utilizing fatty acid oxidation (FAO) and mitochondrial oxidative phosphorylation. Indeed, FAO has been shown to be necessary for M2 activation. This realization has focused our attention on fatty acid metabolism, which since it is essential for M2 activation must, by definition, be an essential face of protection against helminth infections. Fatty acids for FAO are derived from the lysosomal lipolysis of triacylglycerols, which are sourced either from the exterior or through endogenous synthesis of fatty acids. Despite the fact that it is clear that FAO is essential for M2 activation the underlying reasons for the importance of this type of metabolism for M2 activation are unclear. We hypothesize that FAO serves as an efficient source of citrate for export into the cytosol where it can be used for processes that are critical for M2 activation such as synthesis of fatty acids for FAO and to act as ligands for PPARs, and the production of acetate for the acetylation of histones to permit the expression of M2 genes. In addition to their role in immunity
to helminths, M2 macrophages play roles in wound healing, and in whole body metabolic homeostasis. Remarkably, helminth infection has been reported to be capable of mitigating the metabolic consequences of a high fat diet. We hypothesize that strong type 2 immunity induced by helminth infection is able to maintain metabolic homeostasis by broadly supporting M2 activation in tissues distal to the site of infection and will explore this in our third aim. The specific aims of this project are: 1. To establish whether fatty acid synthesis is necessary for M2
activation. 2. To assess the metabolic control of histone acetylation in M2 activation. 3. To determine whether type 2 immunity in helminth infection modulates metabolic homeostasis by broadly supporting M2 activation. We will use genetic loss of function and chemical inhibitor approaches to target key genes encoding enzymes, transcription factors and receptors involved in lipid metabolism to explore M2 activation in reductionist systems and during infection with helminth parasites. We will examine the outcome of alterations in lipid metabolism on infection with these organisms, and will examine the underlying basis for beneficial effects of helminth infections on metabolic disorders associated with obesity.
描述(由适用提供):在许多发展中国家,蠕虫寄生虫是内在的。这些病原体引起的疾病的总体燃烧很高,大约3亿感染了严重发病率。在这里,我们将重点关注M2巨噬细胞,这些巨噬细胞在保护蠕虫感染中的角色至关重要。巨噬细胞可以根据上下文采用不同的激活状态。干扰素与TLR激动剂联合促进M1(或经典)激活,而细胞因子IL-4和IL-13促进M2(或替代)激活。 M1和M2巨噬细胞中的差异功能由不同的核心代谢,M1细胞承诺有氧糖酵解,以及利用脂肪酸氧化(FAO)和线粒体氧化磷酸化的M2巨噬细胞。实际上,粮农组织已被证明是M2激活所必需的。这种认识将我们的注意力集中在脂肪酸代谢上,因为它对于M2激活至关重要,根据定义,必须是保护蠕虫感染的必不可少的面孔。粮农组织的脂肪酸源自三酰基甘油的溶酶体脂解,这些脂肪液来自外部或内源性脂肪酸的合成。尽管很明显,FAO对于M2激活至关重要,但这种代谢对M2激活的重要性的根本原因尚不清楚。我们假设粮农组织是柠檬酸粮农组织的有效来源,用于导出到细胞质中,在其中它可用于对M2激活至关重要的过程,例如fao的合成脂肪酸的合成,并用作PPARS的配体,并用作乙酸盐的产生,以允许M2基因的乙酸乙酸酯的产生。除了它们在免疫中的作用
对于舵手,M2巨噬细胞在伤口愈合和全身代谢稳态中扮演角色。值得注意的是,据报道,蠕虫感染能够减轻高脂饮食的代谢后果。我们假设由蠕虫感染引起的强大的2型免疫诱导能够通过广泛支持感染部位的组织中的M2激活来维持代谢稳态,并将在我们的第三个目标中探索这一点。该项目的具体目的是:1。确定M2是否需要脂肪酸合成
激活。 2。评估M2激活中组蛋白乙酰化的代谢控制。 3。确定2型免疫支持是否通过广泛支持M2激活来代谢稳态。我们将使用功能和化学抑制剂方法的遗传丧失来靶向编码脂质代谢中涉及的酶,转录因子和受体的关键基因,以探索还原主义系统中的M2激活以及在使用蠕虫寄生虫感染期间。我们将研究这些生物感染脂质代谢改变的变化的结果,并将检查蠕虫感染对与肥胖相关的代谢疾病的有益影响的基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EDWARD J. PEARCE其他文献
EDWARD J. PEARCE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EDWARD J. PEARCE', 18)}}的其他基金
MANIPULATING DENDRITIC CELL METABOLISM TO PROMOTE CANCER IMMUNITY
操纵树突状细胞代谢以促进癌症免疫
- 批准号:
9133018 - 财政年份:2016
- 资助金额:
$ 27万 - 项目类别:
MANIPULATING DENDRITIC CELL METABOLISM TO PROMOTE CANCER IMMUNITY
操纵树突状细胞代谢以促进癌症免疫
- 批准号:
9067234 - 财政年份:2016
- 资助金额:
$ 27万 - 项目类别:
MACROPHAGE FATTY ACID METABOLISM IN IMMUNITY TO HELMINTHS
蠕虫免疫中的巨噬细胞脂肪酸代谢
- 批准号:
8887045 - 财政年份:2015
- 资助金额:
$ 27万 - 项目类别:
MANIPULATING DENDRITIC CELL METABOLISM TO PROMOTE CANCER IMMUNITY
操纵树突状细胞代谢以促进癌症免疫
- 批准号:
8370766 - 财政年份:2012
- 资助金额:
$ 27万 - 项目类别:
MANIPULATING DENDRITIC CELL METABOLISM TO PROMOTE CANCER IMMUNITY
操纵树突状细胞代谢以促进癌症免疫
- 批准号:
8843386 - 财政年份:2012
- 资助金额:
$ 27万 - 项目类别:
MANIPULATING DENDRITIC CELL METABOLISM TO PROMOTE CANCER IMMUNITY
操纵树突状细胞代谢以促进癌症免疫
- 批准号:
8677812 - 财政年份:2012
- 资助金额:
$ 27万 - 项目类别:
MANIPULATING DENDRITIC CELL METABOLISM TO PROMOTE CANCER IMMUNITY
操纵树突状细胞代谢以促进癌症免疫
- 批准号:
8519388 - 财政年份:2012
- 资助金额:
$ 27万 - 项目类别:
相似国自然基金
溶酶体酸性脂肪酶调控“疾病相关小胶质细胞”表型转化在缺血性白质损伤修复中的作用及机制
- 批准号:32271033
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
山茱萸环烯醚萜苷类成分通过上调溶酶体酸性脂肪酶抑制肝星状细胞活化的药效及作用机制
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
山茱萸环烯醚萜苷类成分通过上调溶酶体酸性脂肪酶抑制肝星状细胞活化的药效及作用机制
- 批准号:82104687
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
DRG中溶酶体酸性脂肪酶LIPN在神经病理性疼痛的作用和机制
- 批准号:
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
TFEB靶向作用LAL调控脂类自噬改善糖尿病心肌病脂毒性机制研究
- 批准号:81660152
- 批准年份:2016
- 资助金额:35.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Recombinant production of structured fats that mimic human milk fat
重组生产模仿人乳脂肪的结构脂肪
- 批准号:
10822765 - 财政年份:2023
- 资助金额:
$ 27万 - 项目类别:
Liver-Gut-Microbiome Axis and Fatty acid absorption in Preterm Infants
早产儿的肝脏-肠道-微生物轴和脂肪酸吸收
- 批准号:
10635182 - 财政年份:2023
- 资助金额:
$ 27万 - 项目类别:
Role of selective autophagy in aging and neurodegeneration: a small molecule approach
选择性自噬在衰老和神经退行性变中的作用:一种小分子方法
- 批准号:
10573102 - 财政年份:2023
- 资助金额:
$ 27万 - 项目类别:
Dual Fatty Acid Amide Hydrolase (FAAH)/Monoacylglycerol lipase (MAGL) Inhibitors for Cannabis Use Disorder (CUD).
双脂肪酸酰胺水解酶 (FAAH)/单酰基甘油脂肪酶 (MAGL) 抑制剂,用于治疗大麻使用障碍 (CUD)。
- 批准号:
10577008 - 财政年份:2023
- 资助金额:
$ 27万 - 项目类别:
The regulation of renal tubular transport by cannabinoid receptor type 1 (CB1R) and its endogenous lipid ligands
1型大麻素受体(CB1R)及其内源性脂质配体对肾小管转运的调节
- 批准号:
10588113 - 财政年份:2023
- 资助金额:
$ 27万 - 项目类别: